204 related articles for article (PubMed ID: 19425272)
1. Type 2 diabetes and HbA1c targets.
Prescrire Int; 2008 Dec; 17(98):254. PubMed ID: 19425272
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes: target HbA1c of about 7%.
Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
[TBL] [Abstract][Full Text] [Related]
3. [New studies, new strategies, new guidelines: so that diabetic patients will live longer].
Aumiller J
MMW Fortschr Med; 2005 Oct; 147(41):4-6. PubMed ID: 16270500
[No Abstract] [Full Text] [Related]
4. Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
Lipska KJ; Krumholz HM
JAMA; 2017 Mar; 317(10):1017-1018. PubMed ID: 28125758
[No Abstract] [Full Text] [Related]
5. [Intensive therapy in type 2 diabetes. More damage than benefit?].
Einecke D
MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
[No Abstract] [Full Text] [Related]
6. Higher type 2 diabetes-related mortality when HbA1c levels are too low.
Prescrire Int; 2008 Oct; 17(97):213. PubMed ID: 19536943
[TBL] [Abstract][Full Text] [Related]
7. What matters in ADVANCE and ADVANCE-ON.
Hamet P
Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
[TBL] [Abstract][Full Text] [Related]
8. [Glycaemic control and complications of diabetes: what about?].
Bouhanick B; Barigou M; Kantambadouno JB; Chamontin B
Presse Med; 2013 May; 42(5):849-54. PubMed ID: 23540378
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
Meier M; Hummel M
Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions.
Roussel R; Steg PG; Mohammedi K; Marre M; Potier L
Diabetes Obes Metab; 2018 Feb; 20(2):238-244. PubMed ID: 28597588
[TBL] [Abstract][Full Text] [Related]
11. [Hypoglycemia and cardiovascular risk].
Avogaro A
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
[TBL] [Abstract][Full Text] [Related]
12. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
Paty BW
Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
[TBL] [Abstract][Full Text] [Related]
13. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
[TBL] [Abstract][Full Text] [Related]
14. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch M; Hummel M
MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
[No Abstract] [Full Text] [Related]
15. Glycemic targets and cardiovascular disease.
Cefalu WT
N Engl J Med; 2008 Jun; 358(24):2633-5. PubMed ID: 18539919
[No Abstract] [Full Text] [Related]
16. [Questions for practicing internists].
Zinnenlauf S
Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
[No Abstract] [Full Text] [Related]
17. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.
Gerstein HC; Colhoun HM; Dagenais GR; Diaz R; Lakshmanan M; Pais P; Probstfield J; Riddle MC; Rydén L; Xavier D; Atisso CM; Avezum A; Basile J; Chung N; Conget I; Cushman WC; Franek E; Hancu N; Hanefeld M; Holt S; Jansky P; Keltai M; Lanas F; Leiter LA; Lopez-Jaramillo P; Cardona-Munoz EG; Pirags V; Pogosova N; Raubenheimer PJ; Shaw J; Sheu WH; Temelkova-Kurktschiev T;
Diabetes Obes Metab; 2018 Jan; 20(1):42-49. PubMed ID: 28573765
[TBL] [Abstract][Full Text] [Related]
18. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.
Ismail-Beigi F; Moghissi E; Tiktin M; Hirsch IB; Inzucchi SE; Genuth S
Ann Intern Med; 2011 Apr; 154(8):554-9. PubMed ID: 21502652
[TBL] [Abstract][Full Text] [Related]
19. The role of combination therapy in type 2 diabetes in the post-ACCORD era.
Kuritzky L
Curr Diab Rep; 2012 Jun; 12(3):227-9. PubMed ID: 22528598
[No Abstract] [Full Text] [Related]
20. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
